KindlyMD (NASDAQ:NAKA) Shares Gap Up - Here's Why

Key Points

• KindlyMD's share price increased from $1.24 to $1.35 at the market opening, with the latest trading price at $1.41 and a significant volume of 17.7 million shares traded.
• Maxim Group has initiated coverage on KindlyMD with a "buy" rating and set a price target of $8.00, which aligns with the average rating of "Buy" from analysts.
• The company recently reported a negative earnings per share of ($0.34) and had a market capitalization of $567.94 million.

KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report)'s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $1.24, but opened at $1.35. KindlyMD shares last traded at $1.41, with a volume of 17,742,906 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Maxim Group started coverage on KindlyMD in a report on Wednesday, September 3rd. They issued a "buy" rating and a $8.00 target price on the stock. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $8.00.

KindlyMD Stock Performance

The firm's 50-day moving average is $8.04. The firm has a market cap of $529.38 million, a price-to-earnings ratio of -1.63 and a beta of 33.96.

KindlyMD (NASDAQ:NAKA - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported ($0.34) earnings per share (EPS) for the quarter. KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%. The business had revenue of $0.41 million for the quarter.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.